Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 850 of 3284 entries
View as:

A Study of LY3314814 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03222427 Org: User:
Start: 01/15/18 End: 02/16/18 Due: 02/16/19

Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00785408 Org: User:
Start: 12/31/08 End: 09/30/09 Due: 09/30/10

Seroquel XR in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00852631 Org: User:
Start: 02/28/09 End: 05/31/10 Due: 05/31/11

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00831779 Org: User:
Start: 04/30/09 End: 08/31/10 Due: 08/31/11

Acalabrutinib Real World Italian obSErvational Study -ARISE

Phase: N/A Priority: Normal
NCT ID: NCT06205498 Org: User:
Start: 08/08/23 End: 01/08/25 Due: 01/08/26

Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01813474 Org: User:
Start: 03/25/13 End: 08/31/16 Due: 08/31/17

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06005493 Org: User:
Start: 07/11/23 End: 12/16/26 Due: 12/16/27

A Study for Observing Severe Asthma in Patients Treated With Tezepelumab

Phase: N/A Priority: Normal
NCT ID: NCT05677139 Org: User:
Start: 12/13/22 End: 03/31/26 Due: 03/31/27

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Phase: N/A Priority: Normal
NCT ID: NCT04862663 Org: User:
Start: 05/10/21 End: 08/14/29 Due: 08/14/30

The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen

Phase: N/A Priority: Normal
NCT ID: NCT00999466 Org: User:
Start: 10/31/09 End: 12/31/11 Due: 12/31/12

The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01200550 Org: User:
Start: 09/30/10 End: 11/30/11 Due: 11/30/12

GALLANT 4 Tesaglitazar vs. Glibenclamide

Phase: N/A Priority: Normal
NCT ID: NCT00255541 Org: User:
Start: 09/30/04 End: 12/31/06 Due: 12/31/07

A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00746434 Org: User:
Start: 11/30/08 End: 09/30/09 Due: 09/30/10

A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02540668 Org: User:
Start: 09/30/15 End: 01/31/16 Due: 01/31/17

A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03836599 Org: User:
Start: 01/16/19 End: 04/26/19 Due: 04/26/20

A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..

Phase: N/A Priority: Normal
NCT ID: NCT01200524 Org: User:
Start: 10/31/10 End: 04/30/12 Due: 04/30/13

Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Phase: N/A Priority: Normal
NCT ID: NCT01914757 Org: User:
Start: 08/31/13 End: 03/31/16 Due: 03/31/17

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00252824 Org: User:
Start: 07/31/05 End: 12/31/06 Due: 12/31/07

Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin

Phase: N/A Priority: Normal
NCT ID: NCT00722956 Org: User:
Start: 07/31/08 End: 08/31/08 Due: 08/31/09

A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00516074 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin

Phase: N/A Priority: Normal
NCT ID: NCT04118842 Org: User:
Start: 10/17/19 End: 02/26/20 Due: 02/26/21

New Version Pulmicort Turbuhaler USA Children

Phase: N/A Priority: Normal
NCT ID: NCT00642161 Org: User:
Start: 11/30/02 End: 09/30/04 Due: 09/30/05

Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT03761901 Org: User:
Start: 09/21/18 End: 06/19/19 Due: 06/19/20

Symbicort Turbuhaler 30/60 Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01232348 Org: User:
Start: 01/31/10 End: 10/31/11 Due: 10/31/12

Impact of Morning Symptoms in Clinical Control of Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01266395 Org: User:
Start: 01/31/10 End: 07/31/11 Due: 07/31/12